Products and Services
Products and Services
Active pharmaceutical ingredients under development
Product Name
CAS Number
Specification
TP
DMF
Status
Acalabrutinib
1420477-60-6
Q4 2025
Q2 2026
Alpelisib
1217486-61-7
Q4 2025
Q2 2026
Apalutamide
956104-40-8
Q3 2025
Q1 2026
Avapritinib
1703793-34-3
Q4 2025
Q2 2026
Capmatinib
1029712-80-8
Q4 2025
Q2 2026
Darolutamide
1297538-32-9
Q4 2025
Q2 2026
Deucravacitinib
1609392-27-9
Q4 2025
Q2 2026
Encorafenib
1269440-29-0
Q4 2025
Q2 2026
Fedratinib
936091-26-8
Q4 2025
Q2 2026
Gilteritinib
1254053-43-4
Q4 2025
Q2 2026
Inavolisib
2060571-02-8
Q4 2025
Q2 2026
Lapatinib
231277-92-9
Q4 2025
Q2 2026
Lorlatinib
1454846-35-5
Q3 2025
Q1 2026
Pazopanib
444731-52-6
Q1 2026
Q3 2026
Ribociclib
1211441-98-3
Q3 2025
Q1 2026
Ritlecitinib
1792180-81-4
Q3 2025
Q1 2026
Selumetinib
606143-52-6
Q3 2025
Q1 2026
Tepotinib
1100598-32-0
Q4 2025
Q2 2026
Tovorafenib
1096708-71-2
Q4 2025
Q2 2026
Tucatinib
937263-43-9
Q3 2025
Q1 2026
Email:
Company Address:
No.5, Donghai 4th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Taizhou,Zhejiang,China
